- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lumefantrine Solid Dispersion Formulation
Total 11765 results
-
TakedaCompleted
-
University GhentCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedKidney Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedLymphoma | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)UnknownSarcoma | Lymphoma | NeuroblastomaUnited States, Canada
-
Radboud University Medical CenterEuropean Union; Kilimanjaro Christian Medical Centre, TanzaniaCompletedUncomplicated MalariaKenya, Tanzania
-
Moberg Pharma ABCompletedSeborrhoeic Dermatitis of the ScalpSweden
-
Hadassah Medical OrganizationHebrew University of JerusalemUnknownHealthy | BioavailabilityIsrael
-
Hadassah Medical OrganizationUnknown
-
Istanbul UniversityCompleted
-
Novartis PharmaceuticalsCompleted
-
Federico II UniversityAgenzia Italiana del Farmaco; Istituto Biostrutture e Immagini, CNR NaplesCompleted
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Ethical Oncology ScienceCompletedLymphoma, Non-Hodgkin | Solid TumorsSwitzerland, Italy
-
Institut Claudius RegaudMerck Sharp & Dohme LLCTerminatedMalignant Solid TumourFrance
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Singapore National Eye CentreSingapore Eye Research Institute; Nanchang UniversityCompletedGlaucoma | Wound Healing | TrabeculectomySingapore
-
Aposense Ltd.UnknownSolid Tumors | Brain MetastasesUnited States
-
Clinica Universidad de Navarra, Universidad de...UnknownMelanoma | Renal Cell Carcinoma | Carcinoma, HepatocellularSpain
-
Cellectar, IncCompletedSolid TumorsUnited States
-
PfizerCompletedNeoplasms | Breast Cancer | Solid TumorsUnited States
-
PfizerCompleted
-
Millennium Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen-Cilag Ltd.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Schizoaffective Disorders
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Desitin Arzneimittel GmbHFGK Clinical Research GmbHTerminated
-
AstraZenecaCompleted
-
University of UtahCompletedBone Strength | Stress Fractures | Bone Geometry | Biomechanical ChangesUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Indiana University; Greenwich HospitalCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedColorectal NeoplasmsUnited States
-
AstraZenecaCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Kidney Cancer | Testicular Germ Cell Tumor | Breast Cancer | Ovarian Cancer | Gestational Trophoblastic Tumor | NeuroblastomaUnited States
-
Enzon Pharmaceuticals, Inc.CompletedLymphoma | Advanced Solid TumorsUnited States
-
University of California, DavisNational Cancer Institute (NCI)CompletedLung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, DavisNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States